CD8A and cancer: Conversely, transforming growth factor β (TGF-β) has been found to inhibit NK and CD8+ T-cell activity and reduce the expression of major histocompatibility complex (MHC) molecules on the surface of tumor cells, which helps cancer cells to evade immune surveillance and promotes the transformation of normal colon tissues to CRC [19, 20].